SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-008496
Filing Date
2024-03-04
Accepted
2024-03-04 16:10:37
Documents
17
Period of Report
2024-02-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20240228.htm   iXBRL 8-K 31435
2 EX-1.1 exhibit11-closing8xk.htm EX-1.1 220245
3 EX-5.1 exhibit51-closing8xk.htm EX-5.1 19012
7 lathama.jpg GRAPHIC 14559
  Complete submission text file 0001628280-24-008496.txt   474938

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240228.xsd EX-101.SCH 1889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240228_lab.xml EX-101.LAB 24851
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240228_pre.xml EX-101.PRE 13038
18 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240228_htm.xml XML 2835
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 24715066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)